Raplixa Euroopa Liit - eesti - EMA (European Medicines Agency)

raplixa

mallinckrodt pharmaceuticals ireland limited - inimese fibrinogeen, inimese trombiin - hemostaas, kirurgiline - antihemorraagilised ained - toetusravi juhul, kui tavalised kirurgilised meetodid ei ole hemostaasi paranemiseks piisavad. raplixa tuleb kasutada koos heakskiidetud želatiin sponge. raplixa on näidatud täiskasvanute üle 18-aastane.

Rivastigmine 3M Health Care Ltd Euroopa Liit - eesti - EMA (European Medicines Agency)

rivastigmine 3m health care ltd

3m health care limited - rivastigmiin - alzheimeri tõbi - psychoanaleptics, , anticholinesterases - kerge kuni mõõdukalt raskekujulise alzheimeri tõve sümptomaatiline ravi.

Cabometyx Euroopa Liit - eesti - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastilised ained - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

PRASUGREL ALEMBIC õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

prasugrel alembic õhukese polümeerikattega tablett

alembic pharmaceuticals europe limited - prasugreel - õhukese polümeerikattega tablett - 10mg 56tk; 10mg 14tk

Nevirapine Teva Euroopa Liit - eesti - EMA (European Medicines Agency)

nevirapine teva

teva b.v.  - nevirapiin - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - nevirapine teva on näidustatud kombinatsioonis teiste retroviirusevastaste ravimitega hiv-1 nakatunud täiskasvanute, noorukite ja igas vanuses laste raviks. enamik kogemusi nevirapine on koos nucleoside reverse transcriptase inhibiitorid (nrtis). valida järgnevate pärast ravi nevirapine tuleks põhinevad kliiniliste kogemuste ja vastupanu testimine.

Revolade Euroopa Liit - eesti - EMA (European Medicines Agency)

revolade

novartis europharm limited - eltrombopag - idiopaatiline, trombotsütopeeniline purpur - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Zinforo Euroopa Liit - eesti - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials süsteemseks kasutamiseks, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

NEVIRAPINE ACCORD toimeainet prolongeeritult vabastav tablett Eesti - eesti - Ravimiamet

nevirapine accord toimeainet prolongeeritult vabastav tablett

accord healthcare b.v. - nevirapiin - toimeainet prolongeeritult vabastav tablett - 400mg 90tk; 400mg 30tk

CLINDAMYCIN - MIP 300 õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

clindamycin - mip 300 õhukese polümeerikattega tablett

mip pharma gmbh - klindamütsiin - õhukese polümeerikattega tablett - 300mg 16tk; 300mg 12tk; 300mg 30tk

ERSET õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

erset õhukese polümeerikattega tablett

rivopharm limited - sertraliin - õhukese polümeerikattega tablett - 100mg 100tk; 100mg 20tk; 100mg 50tk; 100mg 42tk; 100mg 98tk; 100mg 28tk